Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Sanofi    SAN   FR0000120578

SANOFI (SAN)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
Most relevant news about SANOFI
08/16Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Prov..
AQ
08/16THERAPEUTIC VACCINES MARKET 2018 : Global Industry Future Analysis & Growth by T..
AQ
08/16POMPE DISEASE MARKET IS GROWING AT A : Pompe Disease Market – Global Indus..
AQ
08/13SANOFI : Disclosure of trading in own shares
GL
08/07Biotech entrepreneur Drayson plans to list new AI drug research firm
RE
08/07SANOFI : Shanghai Junshi planning Hong Kong IPO
AQ
08/06SANOFI : Disclosure of trading in own shares
GL
08/06SANOFI : Disclosure of trading in own shares
AQ
08/02Lexicon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Pro..
AQ
08/02SANOFI : Stockpiles amid fears of a no deal brexit
AQ
08/01More drugmakers build Brexit stockpiles as EU agency faces exodus
RE
08/01SANOFI : Has Been Stockpiling Drugs for No-Deal Brexit for Six Months -- 2nd Upd..
DJ
08/01SANOFI : Correction to Sanofi Stockpiling Story on Tuesday
DJ
08/01SANOFI : Has Been Stockpiling Drugs for No-Deal Brexit for Six Months -- Update
DJ
08/01Sanofi drops two clinical assets; reports rebounding Dupixent sales
AQ
More most relevant news
All news about SANOFI
08/16Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Prov..
AQ
08/16THERAPEUTIC VACCINES MARKET 2018 : Global Industry Future Analysis & Growth by T..
AQ
08/16POMPE DISEASE MARKET IS GROWING AT A : Pompe Disease Market – Global Indus..
AQ
08/15SANOFI : The Top 50 Generic Drug Producers Had Combined Revenues of $92bn in 201..
AQ
08/13SANOFI : Disclosure of trading in own shares
GL
08/11SANOFI : Early Phase Results Promising for BTK Inhibitor in Multiple Sclerosis T..
AQ
08/10SANOFI : Polluting Sanofi factory allowed to partially resume manufacturing
AQ
08/09SANOFI : Recent Studies from Sanofi Pasteur Add New Data to Hepatitis (Host cell..
AQ
08/09SANOFI : Study Findings on Eye Proteins Are Outlined in Reports from Sanofi (Com..
AQ
08/09SANOFI : Studies from Sanofi Pasteur Have Provided New Data on Dengue Hemorrhagi..
AQ
More news
Sector news : Pharmaceuticals - NEC
08/16TEVA PHARMACEUTICAL INDUSTRIES : Antares Pharma Shares Rise After FDA Approves F..
DJ
08/16GLAXOSMITHKLINE : to Close Skincare Factory in Ireland
DJ
08/16BASF : Bayer says can begin integration of Monsanto
RE
08/16REGENERON PHARMACEUTICALS : Teva Report Positive Phase 3 Fasinumab Results
DJ
08/16PFIZER : BioNTech in $425 Million Flu Vaccine Collaboration
DJ
08/16BAYER : Shares Suffer as Bad News Mounts Up
DJ
More sector news : Pharmaceuticals - NEC
Official Publications
07/26Nomination 
06/30Monthly statement on outstanding equity shares and voting rights 
06/19Nomination 
05/31Monthly statement on outstanding equity shares and voting rights 
05/02Proxy Statments 
04/30Monthly statement on outstanding equity shares and voting rights 
More official Publications
News from SeekingAlpha
08/15Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2018 Update 
08/14Eton Pharmaceuticals Files For U.S. IPO 
08/13Amicus Receives First FDA Approval For Fabry Disease Treatment In 15 Years 
08/13Alnylam Receives First Ever FDA Approval For RNAi Therapeutic Treating Rare D.. 
08/10Premarket analyst action - healthcare 
08/09U.S. Moats Ahead Despite IT Underweight 
Latest Tweets
08/16SOCIAL ACTIVITY: $SNY - SANOFI ? TradeIdeas via ?  
08/16MOST ACTIVE ALERT: $SNY SANOFI ? TradeIdeas via  
08/16Teva and Regeneron's Fasinumab Meets Primary and Secondary Endpoints in Patie..
2
08/16Germany’s BioNTech has established itself at the forefront of the mRNA field,..
4
08/15Head-To-Head Survey: Tocagen $TOCA and Sanofi $SNY  
More tweets
Qtime:179
STOCK PICK
At a Crossroads
Financials (€)
Sales 2018 35 025 M
EBIT 2018 8 524 M
Net income 2018 5 102 M
Debt 2018 16 254 M
Yield 2018 4,25%
P/E ratio 2018 17,49
P/E ratio 2019 16,41
EV / Sales 2018 3,04x
EV / Sales 2019 2,94x
Capitalization 90 311 M
Chart SANOFI
Duration : Period :
Sanofi Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SANOFI
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 79,6 €
Spread / Average Target 10%
EPS Revisions
Managers
NameTitle
Olivier Brandicourt Chief Executive Officer & Director
Serge Weinberg Chairman
Jérôme Contamine Chief Financial Officer & Executive VP-Finance
Ameet Nathwani Executive Vice President-Medical Affairs
John C. Reed Head-Global Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
SANOFI1.13%102 916
JOHNSON & JOHNSON-5.18%347 417
PFIZER14.36%238 136
NOVARTIS-0.83%207 488
ROCHE HOLDING LTD.-2.96%206 696
MERCK AND COMPANY22.36%176 752